![](/img/cover-not-exists.png)
Clinically significant adverse effects in a Phase 1 testing program
Zarafonetis, Chris J. D., Riley, Philip A., Willis, Park W., Power, Lawrence H., Werbelow, Judson, Farhat, Leo, Beckwith, Wendall, Marks, Bernard H.Volume:
24
Language:
english
Journal:
Clinical Pharmacology & Therapeutics
DOI:
10.1002/cpt1978242127
Date:
August, 1978
File:
PDF, 755 KB
english, 1978